|FDA Transparency Task Force Update|
|By Jamie Tera|
|Friday, 03 July 2009 06:59|
As some of our readers may know, the Food and Drug Administration (FDA) has formed a task force to develop recommendations for making useful and understandable information about FDA activities and decision making more readily available to the public in a timely manner and in a user-friendly format.Many BioMed investors are unhappy with how the FDA is conducting business lately. Delays, suspicions about political agendas, and other concerns top the list of complaints on message boards and e-mails received by our staff.
The Task Force is seeking public opinion on how to make the agency’s information on activities and decision making more transparent, useful, and understandable to the public, while appropriately protecting confidential information.
FDA held a public meeting on Wed., June 24, 2009, to solicit input from interested persons on ways for the agency to make useful and understandable information about FDA activities and decision making more readily available to the public in a timely manner and in a user-friendly format.
Provides opportunities to learn and provide feedback on what FDA is doing, the basis for FDA's decisions, and the processes used to make agency decisions. The blog will run for the next six months (June through November 2009).